Les endocardites fongiques : mise au point View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-04-22

AUTHORS

P. Fillâtre, M. Revest, P. Tattevin

ABSTRACT

While it used to affect mostly intravenous drug users and patients who underwent cardiac surgery, during the years 1965-1995’s, fungal endocarditis is currently mostly observed in severely immunocompromised patients, with chronic central venous access and/or broad-spectrum antibiotic use, or total parenteral nutrition. The requirement of specific blood culture bottles for fungus has virtually disappeared, thanks to the optimization of automated blood culture systems. Meanwhile, the advent of several blood tests for invasive mycosis–galactomannan for invasive aspergillosis, mannan/anti-mannan antibodies for candidemia and β-1,3-D glucans for any invasive mycosis–shall improve sensitivity, and reduce diagnosis delay, although limited data are available on their yield for the diagnosis of fungal endocarditis. New antifungal agents available since the early 2000s probably represent dramatic improvement for fungal endocarditis: 1) a new class, echinocandins, has the potential to improve the management of Candida sp. endocarditis, due to its fungicidal effect on yeasts, and the tolerability of increased doses; 2) voriconazole improved survival in patients with invasive aspergillosis, as compared to amphotericin B, and this achievement may apply to Aspergillus sp. endocarditis as well, although the prognosis of these latter remains dismal and largely dependent on cardiac surgery. More... »

PAGES

348-360

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13546-016-1199-y

DOI

http://dx.doi.org/10.1007/s13546-016-1199-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038532707


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fill\u00e2tre", 
        "givenName": "P.", 
        "id": "sg:person.01273730565.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Revest", 
        "givenName": "M.", 
        "id": "sg:person.01126473407.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126473407.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Maladies infectieuses et r\u00e9animation m\u00e9dicale, h\u00f4pital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, universit\u00e9 Rennes-1, F-35033, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tattevin", 
        "givenName": "P.", 
        "id": "sg:person.01262110414.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262110414.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/cc9365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035798140", 
          "https://doi.org/10.1186/cc9365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc13953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043495383", 
          "https://doi.org/10.1186/cc13953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-005-0038-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033825287", 
          "https://doi.org/10.1007/s10096-005-0038-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-008-0466-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031927093", 
          "https://doi.org/10.1007/s10096-008-0466-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-015-2384-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016356921", 
          "https://doi.org/10.1007/s10096-015-2384-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11908-008-0045-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002398802", 
          "https://doi.org/10.1007/s11908-008-0045-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-04-22", 
    "datePublishedReg": "2016-04-22", 
    "description": "While it used to affect mostly intravenous drug users and patients who underwent cardiac surgery, during the years 1965-1995\u2019s, fungal endocarditis is currently mostly observed in severely immunocompromised patients, with chronic central venous access and/or broad-spectrum antibiotic use, or total parenteral nutrition. The requirement of specific blood culture bottles for fungus has virtually disappeared, thanks to the optimization of automated blood culture systems. Meanwhile, the advent of several blood tests for invasive mycosis\u2013galactomannan for invasive aspergillosis, mannan/anti-mannan antibodies for candidemia and \u03b2-1,3-D glucans for any invasive mycosis\u2013shall improve sensitivity, and reduce diagnosis delay, although limited data are available on their yield for the diagnosis of fungal endocarditis. New antifungal agents available since the early 2000s probably represent dramatic improvement for fungal endocarditis: 1) a new class, echinocandins, has the potential to improve the management of Candida sp. endocarditis, due to its fungicidal effect on yeasts, and the tolerability of increased doses; 2) voriconazole improved survival in patients with invasive aspergillosis, as compared to amphotericin B, and this achievement may apply to Aspergillus sp. endocarditis as well, although the prognosis of these latter remains dismal and largely dependent on cardiac surgery.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13546-016-1199-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1295852", 
        "issn": [
          "1624-0693", 
          "2496-6142"
        ], 
        "name": "M\u00e9decine Intensive R\u00e9animation", 
        "publisher": "Lavoisier", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "fungal endocarditis", 
      "cardiac surgery", 
      "invasive aspergillosis", 
      "broad-spectrum antibiotic use", 
      "chronic central venous access", 
      "central venous access", 
      "total parenteral nutrition", 
      "intravenous drug users", 
      "anti-mannan antibodies", 
      "venous access", 
      "parenteral nutrition", 
      "blood tests", 
      "new antifungal agents", 
      "antibiotic use", 
      "diagnosis delay", 
      "invasive mycosis", 
      "endocarditis", 
      "blood culture system", 
      "drug users", 
      "blood culture bottles", 
      "amphotericin B", 
      "patients", 
      "limited data", 
      "surgery", 
      "antifungal agents", 
      "aspergillosis", 
      "culture bottles", 
      "culture system", 
      "dramatic improvement", 
      "tolerability", 
      "prognosis", 
      "candidemia", 
      "Candida sp", 
      "voriconazole", 
      "doses", 
      "diagnosis", 
      "fungicidal effect", 
      "echinocandins", 
      "years 1965", 
      "mycosis", 
      "antibodies", 
      "survival", 
      "nutrition", 
      "au point", 
      "agents", 
      "management", 
      "sensitivity", 
      "test", 
      "effect", 
      "improvement", 
      "Aspergillus sp", 
      "use", 
      "advent", 
      "data", 
      "access", 
      "bottles", 
      "delay", 
      "new class", 
      "potential", 
      "LE", 
      "point", 
      "sp", 
      "system", 
      "class", 
      "fungi", 
      "achievement", 
      "requirements", 
      "yeast", 
      "users", 
      "thanks", 
      "yield", 
      "optimization", 
      "specific blood culture bottles", 
      "invasive mycosis\u2013galactomannan", 
      "mycosis\u2013galactomannan", 
      "mannan/anti-mannan antibodies"
    ], 
    "name": "Les endocardites fongiques : mise au point", 
    "pagination": "348-360", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038532707"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13546-016-1199-y"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13546-016-1199-y", 
      "https://app.dimensions.ai/details/publication/pub.1038532707"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_689.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13546-016-1199-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13546-016-1199-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13546-016-1199-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13546-016-1199-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13546-016-1199-y'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      22 PREDICATES      107 URIs      93 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13546-016-1199-y schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N2391af27a8764797b5da1c15b997f0eb
4 schema:citation sg:pub.10.1007/s10096-005-0038-2
5 sg:pub.10.1007/s10096-008-0466-x
6 sg:pub.10.1007/s10096-015-2384-z
7 sg:pub.10.1007/s11908-008-0045-4
8 sg:pub.10.1186/cc13953
9 sg:pub.10.1186/cc9365
10 schema:datePublished 2016-04-22
11 schema:datePublishedReg 2016-04-22
12 schema:description While it used to affect mostly intravenous drug users and patients who underwent cardiac surgery, during the years 1965-1995’s, fungal endocarditis is currently mostly observed in severely immunocompromised patients, with chronic central venous access and/or broad-spectrum antibiotic use, or total parenteral nutrition. The requirement of specific blood culture bottles for fungus has virtually disappeared, thanks to the optimization of automated blood culture systems. Meanwhile, the advent of several blood tests for invasive mycosis–galactomannan for invasive aspergillosis, mannan/anti-mannan antibodies for candidemia and β-1,3-D glucans for any invasive mycosis–shall improve sensitivity, and reduce diagnosis delay, although limited data are available on their yield for the diagnosis of fungal endocarditis. New antifungal agents available since the early 2000s probably represent dramatic improvement for fungal endocarditis: 1) a new class, echinocandins, has the potential to improve the management of Candida sp. endocarditis, due to its fungicidal effect on yeasts, and the tolerability of increased doses; 2) voriconazole improved survival in patients with invasive aspergillosis, as compared to amphotericin B, and this achievement may apply to Aspergillus sp. endocarditis as well, although the prognosis of these latter remains dismal and largely dependent on cardiac surgery.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf N60749835de41498282250c3f77ce550c
17 Nb4f9a0c4c1d54bd68063d88a827c9373
18 sg:journal.1295852
19 schema:keywords Aspergillus sp
20 Candida sp
21 LE
22 access
23 achievement
24 advent
25 agents
26 amphotericin B
27 anti-mannan antibodies
28 antibiotic use
29 antibodies
30 antifungal agents
31 aspergillosis
32 au point
33 blood culture bottles
34 blood culture system
35 blood tests
36 bottles
37 broad-spectrum antibiotic use
38 candidemia
39 cardiac surgery
40 central venous access
41 chronic central venous access
42 class
43 culture bottles
44 culture system
45 data
46 delay
47 diagnosis
48 diagnosis delay
49 doses
50 dramatic improvement
51 drug users
52 echinocandins
53 effect
54 endocarditis
55 fungal endocarditis
56 fungi
57 fungicidal effect
58 improvement
59 intravenous drug users
60 invasive aspergillosis
61 invasive mycosis
62 invasive mycosis–galactomannan
63 limited data
64 management
65 mannan/anti-mannan antibodies
66 mycosis
67 mycosis–galactomannan
68 new antifungal agents
69 new class
70 nutrition
71 optimization
72 parenteral nutrition
73 patients
74 point
75 potential
76 prognosis
77 requirements
78 sensitivity
79 sp
80 specific blood culture bottles
81 surgery
82 survival
83 system
84 test
85 thanks
86 tolerability
87 total parenteral nutrition
88 use
89 users
90 venous access
91 voriconazole
92 years 1965
93 yeast
94 yield
95 schema:name Les endocardites fongiques : mise au point
96 schema:pagination 348-360
97 schema:productId N0470833836fe4be2a2959cc59aaf0d01
98 Nbad6183a3a4546e5a7131e62b1fa55b5
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038532707
100 https://doi.org/10.1007/s13546-016-1199-y
101 schema:sdDatePublished 2022-01-01T18:38
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher N2b2fd66a5ce84db6ac40bb2003408a83
104 schema:url https://doi.org/10.1007/s13546-016-1199-y
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N0470833836fe4be2a2959cc59aaf0d01 schema:name doi
109 schema:value 10.1007/s13546-016-1199-y
110 rdf:type schema:PropertyValue
111 N2391af27a8764797b5da1c15b997f0eb rdf:first sg:person.01273730565.40
112 rdf:rest Nb62cd94d08214616a445f00fc4ea4213
113 N2b2fd66a5ce84db6ac40bb2003408a83 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N3d0eebd5d03a43418a6c870c959db3d3 rdf:first sg:person.01262110414.63
116 rdf:rest rdf:nil
117 N60749835de41498282250c3f77ce550c schema:issueNumber 3
118 rdf:type schema:PublicationIssue
119 Nb4f9a0c4c1d54bd68063d88a827c9373 schema:volumeNumber 25
120 rdf:type schema:PublicationVolume
121 Nb62cd94d08214616a445f00fc4ea4213 rdf:first sg:person.01126473407.04
122 rdf:rest N3d0eebd5d03a43418a6c870c959db3d3
123 Nbad6183a3a4546e5a7131e62b1fa55b5 schema:name dimensions_id
124 schema:value pub.1038532707
125 rdf:type schema:PropertyValue
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
130 schema:name Cardiorespiratory Medicine and Haematology
131 rdf:type schema:DefinedTerm
132 sg:journal.1295852 schema:issn 1624-0693
133 2496-6142
134 schema:name Médecine Intensive Réanimation
135 schema:publisher Lavoisier
136 rdf:type schema:Periodical
137 sg:person.01126473407.04 schema:affiliation grid-institutes:None
138 schema:familyName Revest
139 schema:givenName M.
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126473407.04
141 rdf:type schema:Person
142 sg:person.01262110414.63 schema:affiliation grid-institutes:None
143 schema:familyName Tattevin
144 schema:givenName P.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262110414.63
146 rdf:type schema:Person
147 sg:person.01273730565.40 schema:affiliation grid-institutes:None
148 schema:familyName Fillâtre
149 schema:givenName P.
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40
151 rdf:type schema:Person
152 sg:pub.10.1007/s10096-005-0038-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033825287
153 https://doi.org/10.1007/s10096-005-0038-2
154 rdf:type schema:CreativeWork
155 sg:pub.10.1007/s10096-008-0466-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031927093
156 https://doi.org/10.1007/s10096-008-0466-x
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s10096-015-2384-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1016356921
159 https://doi.org/10.1007/s10096-015-2384-z
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/s11908-008-0045-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002398802
162 https://doi.org/10.1007/s11908-008-0045-4
163 rdf:type schema:CreativeWork
164 sg:pub.10.1186/cc13953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043495383
165 https://doi.org/10.1186/cc13953
166 rdf:type schema:CreativeWork
167 sg:pub.10.1186/cc9365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035798140
168 https://doi.org/10.1186/cc9365
169 rdf:type schema:CreativeWork
170 grid-institutes:None schema:alternateName Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, université Rennes-1, F-35033, Rennes, France
171 schema:name Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, rue Le Guilloux, centre hospitalier de Rennes, université Rennes-1, F-35033, Rennes, France
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...